Ingo H. Gorr
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
Viral Infectious Diseases and Gene Expression in Insects, Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Microtubule and mitosis dynamics, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy(2014)1,342 cited
- → Mobilization of Processed, Membrane-Tethered SPT23 Transcription Factor by CDC48UFD1/NPL4, a Ubiquitin-Selective Chaperone(2001)443 cited
- → Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines(2017)275 cited
- → Mutual Inhibition of Separase and Cdk1 by Two-Step Complex Formation(2005)206 cited
- → Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors(2014)77 cited
- → Essential CDK1-inhibitory role for separase during meiosis I in vertebrate oocytes(2006)64 cited
- → miRNA engineering of CHO cells facilitates production of difficult‐to‐express proteins and increases success in cell line development(2017)56 cited
- → Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology(2020)55 cited
- → Unraveling what makes a monoclonal antibody difficult‐to‐express: From intracellular accumulation to incomplete folding and degradation via ERAD(2019)50 cited
- → Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach(2012)39 cited